Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Retained Earnings (2014 - 2026)

Mesoblast (MESO) posted Retained Earnings of $106.3 million for Q4 2025, up 6.83% sequentially from $99.5 million in Q2 2025, and up 8.74% YoY from $97.8 million in Q4 2024.

Analysis

Mesoblast (MESO) Retained Earnings (2014 - 2026) Analysis & Trends

Mesoblast has reported Retained Earnings for 11 years, with the latest figure at $106.3 million in Q4 2025.

  • Quarterly Retained Earnings rose 8.74% year-over-year to $106.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $106.3 million (up 8.74% YoY) and the FY2025 annual result came in at $99.5 million, up 110.95% from the prior year.
  • Retained Earnings rose to $106.3 million in Q4 2025 per MESO's latest filing, from $99.5 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $106.3 million in Q4 2025 and troughed at -$908.8 million in Q2 2024.
  • A 5-year average of $16.5 million and a median of $73.6 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2024 and 2025: Retained Earnings tumbled 996.51% in 2024, then jumped 110.95% in 2025.
  • Over 5 years, Retained Earnings stood at $68.1 million in 2021, then gained by 6.6% to $72.6 million in 2022, then climbed by 4.51% to $75.8 million in 2023, then climbed by 28.88% to $97.8 million in 2024, then gained by 8.74% to $106.3 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods registered $106.3 million, $99.5 million, and $97.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Mesoblast 2.24 Bn 2.14 Bn - -1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.07 Bn
Dec 31, 2025 -1.05 Bn
Jun 30, 2025 -1.01 Bn
Dec 31, 2024 -956.70 Mn
Jun 30, 2024 -908.76 Mn
Dec 31, 2023 -853.34 Mn
Jun 30, 2023 -820.81 Mn
Mar 31, 2023 -798.89 Mn
Dec 31, 2022 -780.29 Mn
Sep 30, 2022 -755.80 Mn
Jun 30, 2022 -738.92 Mn
Mar 31, 2022 -717.46 Mn
Dec 31, 2021 -696.16 Mn
Sep 30, 2021 -670.21 Mn
Jun 30, 2021 -647.57 Mn
Mar 31, 2021 -625.51 Mn
Dec 31, 2020 -598.99 Mn
Sep 30, 2020 -573.30 Mn
Jun 30, 2020 -548.76 Mn
Mar 31, 2020 -516.15 Mn